Thursday, 2 May 2019

Biomarker may predict if immunotherapy is right choice for colorectal cancer patients

Foundational research by a City of Hope physician-scientist and his colleagues could one day help metastatic colorectal cancer patients decide whether to choose immunotherapy or chemotherapy as their first treatment option.

* This article was originally published here